178 related articles for article (PubMed ID: 2109582)
21. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
[TBL] [Abstract][Full Text] [Related]
22. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
Maejima T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.
Okamoto S; Hamana Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1987 Jul; 31(7):1111-6. PubMed ID: 3499115
[TBL] [Abstract][Full Text] [Related]
24. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
Neu HC
Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
[TBL] [Abstract][Full Text] [Related]
25. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S
J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
[TBL] [Abstract][Full Text] [Related]
26. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
Yang Y; Bhachech N; Bush K
J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
[TBL] [Abstract][Full Text] [Related]
27. Cefotaxime: binding affinity to penicillin-binding proteins and morphological changes of Escherichia coli and Pseudomonas aeruginosa.
Masuyoshi S; Inoue M; Takaoka M; Mitsuhashi S
Arzneimittelforschung; 1981; 31(7):1070-2. PubMed ID: 6268122
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology and toxicology of oral cephalosporins.
Gialdroni Grassi G
Antibiot Chemother (1971); 1995; 47():8-33. PubMed ID: 8554309
[No Abstract] [Full Text] [Related]
29. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance.
Grieco MH
Med Clin North Am; 1982 Jan; 66(1):25-37. PubMed ID: 7038332
[No Abstract] [Full Text] [Related]
31. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
Wise R; Cross C; Andrews JM
Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
[TBL] [Abstract][Full Text] [Related]
32. Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.
Collatz E; Gutmann L; Williamson R; Acar JF
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():13-21. PubMed ID: 6334073
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of cefodizime.
Knothe H; Shah PM
Infection; 1992; 20 Suppl 1():S3-8. PubMed ID: 1526673
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of action of cephalosporins and resistance caused by decreased affinity for penicillin-binding proteins in Bacteroides fragilis.
Yotsuji A; Mitsuyama J; Hori R; Yasuda T; Saikawa I; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1988 Dec; 32(12):1848-53. PubMed ID: 3266730
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
Tsuji A
Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
[No Abstract] [Full Text] [Related]
36. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactam.
Chantot JF; Klich M; Teutsch G; Bryskier A; Collette P; Markus A; Seibert G
Antimicrob Agents Chemother; 1992 Aug; 36(8):1756-63. PubMed ID: 1416860
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo activities of DQ-2556 and its mode of action.
Tanaka M; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1992 Dec; 36(12):2595-601. PubMed ID: 1482128
[TBL] [Abstract][Full Text] [Related]
39. beta-lactam antibiotics.
Walker T; Muggleton PW; O'Callaghan CH
G Ital Chemioter; 1979; 26(1-2):3-16. PubMed ID: 400142
[No Abstract] [Full Text] [Related]
40. Cephabacins, new cephem antibiotics of bacterial origin. IV. Antibacterial activities, stability to beta-lactamases and mode of action.
Nozaki Y; Okonogi K; Katayama N; Ono H; Harada S; Kondo M; Okazaki H
J Antibiot (Tokyo); 1984 Dec; 37(12):1555-65. PubMed ID: 6335505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
